Cardiovascular Journal of Africa: Vol 27 No 6 (November/December 2016)

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 6, November/December 2016

398

AFRICA

Weir MR, Bakris GL, Bushinsky DA,

et al

. Patiromer in patients with

kidney disease and hyperkalemia receiving RAAS Inhibitors.

N Engl J

Med

2015;

372

: 211–221.

Kosiborod M, Rasmussen HS, Lavin P,

et al

. Effect of sodium zirconium

cyclosilicate on potassium lowering for 28 days among outpatients with

hyperkalemia: The HARMONIZE randomized clinical trial.

J Am Med

Assoc

2014;

312

(21): 2223–2233.

Vidal-Petiot E, Ford I, Greenlaw N,

et al

. Cardiovascular event rates and

mortality according to achieved systolic and diastolic blood pressure in

patients with stable CAD: an international cohort study.

Lancet

2016;

Aug 26 (Epub ahead of print).

Jousilahti P, Laatikainen T, Peltonen M,

et al

. Primary prevention and

risk factor reduction in coronary heart disease mortality among work-

ing aged men and women in eastern Finland over 40 years: population

based observational study.

Br Med J

2016;

352

: i721.

McEvoy RD, Antic NA, Heeley E,

et al.

CPAP for prevention of cardio-

vascular events in obstructive sleep apnea.

N Engl J Med

2016; Aug 28

(Epub ahead of print).

Ripley P, Brown M, Everett C,

et al

. Rationale and design of the Clinical

Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease

2 (CE-MARC 2): A prospective, multicenter, randomized trial of diag-

nostic strategies in suspected coronary heart disease.

Am Heart J

2015;

169

(1): 17–24.e1

10. Wallentin L, Lindhagen L, Arnstrom E,

et al

. Early invasive versus

non-invasive treatment in patients with non-ST elevation acute coronary

syndrome (FRISC-II): a 15-year follow-up of a prospective randomised

multicentre study.

Lancet

2016; Aug 25 (Epub ahead of print).

11. Motovska Z, Hlinomaz O, Maklik R,

et al.

Prasugrel versus ticagrelor

in patients with acute myocardial infarction treated with primary percu-

taneous coronary intervention: Multicentre randomized PRAGUE 18

study.

Circulation

2016; Aug 30 (Epub ahead of print).

12. Bonaak M, Annsverk J, Wiseth R,

et al.

Drug-eluting or bare metal

stents for coronary artery disease (NORSTENT).

N Engl J Med

2016;

Aug 19 (Epub ahead of print).

13. Stefanini GG, Behan M, Valgimigli M. Will LEADERS-FREE

change my practice? A randomised double-blind comparison of the

BioFreedom

drug-coated stent versus Gazelle

bare metal stent in

patients at high bleeding risk using a short (1 month) course of dual

antiplatelet therapy.

EuroIntervention

2016;

(6): 798–800.

14. Yamaji K, Raber L, Zanchin T. Ten-year clinical outcomes of first-

generation drug-eluting stents: the sirolimus-eluting vs paclitaxel-eluting

stents for coronary revascularization (ZIRTAX) VERY LATE trial.

Eur

Heart J

2016; Aug 30 (Epub ahead of print).

15. Danzi GB, Piccolo R, Chevalier B. Five-year clinical performance of

a biodegradable polymer-coated biolimus-eluting stent in unselected

patients.

Heart

2016; Aug 10 (Epub ahead of print).

16. Onuma YY, Solomi Y, Shiomi H,

et al.

Two-year clinical, angiographic

and serial optical coherence tomographic follow-up after implementa-

tion of an everolimus-eluting bioresorbable scaffold and an everolimus-

eluting metallic stent: insight from the randomised ABSORB Japan

trial.

EuroIntervention

2016; Jul 6:

(7) (Epub ahead of print).

17. Ferenc M, Gick M, Comberg T,

et al

. Culotte stenting vs TAP stenting

for treatment of de-novo coronary bifurcation lesions with the need for

side-branch stenting: the Bifurcations Bad Krozingen (BBK) II angio-

graphic trial.

Eur Heart J

2016; Aug 30 (Epub ahead of print).

18. Jia H, Dal J, Hon J,

et al.

Effective anti-thrombotic therapy without

stenting: intravascular optical coherence tomography-based manage-

ment in plaque erosion (the EROSION study).

Eur Heart J

2016; Aug

30 (Epub ahead of print).

19. Resor CD, Nathan A, Kereiakes DF,

et al

. Impact of optimal medical

therapy in the dual antiplatelet therapy study.

Circulation

2016; Aug 30

(Epub ahead of print).

20. Baber U, Farkouh ME, Arbel Y,

et al.

Comparative efficacy of coronary

artery bypass surgery vs percutaneous coronary intervention in patients

with diabetes and multivessel coronary artery disease with or without

chronic kidney disease.

Eur Heart J

2016; Aug 29 (Epub ahead of print).

21. Kober L, Thune JJ, Nielsen JC

, et al

. Defibrillator implantation in

patients with nonischemic systolic heart failure.

N Engl J Med

2016; Aug

27 (Epub ahead of print).

22. Zamorano JL, Lancellotti P, Rodriguez Munoz D,

et al.

2016 ESC posi-

tion paper on cancer treatments and cardiovascular toxicity developed

under the auspices of the ESC Committee for Practice Guidelines:

The Task Force for cancer treatments and cardiovascular toxicity of

the European Society of Cardiology (ESC).

Eur Heart J

2016; Aug 26

(Epub ahead of print).

23. Goette A, Merino JL, Ezekowitz MD,

et al

. Edoxaban versus enoxapa-

rin-warfarin in patients undergoing cardioversion of atrial fibrillation

(ENSURE-AF): a randomised, open-label, phase 3b trial.

Lancet

2016;

Aug 26 (Epub ahead of print).

24. Connolly SJ, Milling TJ Jr, Eikelboom JW,

et al.

Andexanet alfa for

acute major bleeding associated with factor Xa inhibitors.

N Engl J Med

2016; Aug 30 (Epub ahead of print).

25. Bongianino R, Priori SG. Gene therapy to treat cardiac arrhythmias.

Nat Rev Cardiol

2015;

(9): 531–546.

Events

23rd Annual Conference of The Egyptian Society of Cardiothoracic Surgery

23rd annual conference of The Egyptian Society of Cardiothoracic

Surgery in collaboration with National Heart Institute of Egypt, from

4–7 April 2017 at Mena House Hotel, Cairo, Egypt.

Workshops:

RV-PA conduit implantation, electrophysiology anatomy for

ablation surgery, aortic repair, simulation for wire-based techniques, basic

anatomy of the heart for junior staff, TEE for surgeons and anaesthetics,

endoscopic vein harvesting, coronary anastomoses (hands on).

Main topics:

minimal invasive surgery, aortic root surgery, TEVAR,

surgery for heart failure, cardiovascular perfusion, RV-PA connections,

AV valve repair in infants, staging modalities in lung cancer, woman in

cardiac surgery, personal skill development for surgeons.

Kindly submit abstracts before the deadline 31 December 2016. Please

check the link for abstract form: